CLOV vs PLSE · rev $1.37B vs $1.03B cap
Clover Health Investments Corp (CLOV) versus Pulse Biosciences Inc (PLSE) — a side-by-side from cached financials, not a winner call.
Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.
Pulse Biosciences Inc (PLSE) is a medical instruments & supplies company listed on US.
Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.
Latest reported PLSE revenue for 2024-12-31 was $0. Net income was -$53.6M. PLSE currently screens at market cap $1.03B.
CLOV currently screens at market cap $1.55B. PLSE currently screens at market cap $1.03B.
Not investment advice. Open the CLOV and PLSE stock pages for the full models.
Not investment advice.